A new translocation (4;12)(q21;q15) after combined immunosuppressive therapy in a case of hypoplastic myelodysplastic syndrome with translocation (12;15)(q23;q12)
Iwanaga
M
M
Sadamori
N
N
Amenomori
T
T
Kawaguchi
Y
Y
Nakamura
H
H
Matsuo
T
T
Kuriyama
K
K
Tomonaga
M
M
D000753:Anemia, Refractory / Q000188:drug therapy / Q000235:genetics*; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D002881:Chromosomes, Human, Pair 12 / Q000235:genetics*; D002884:Chromosomes, Human, Pair 15 / Q000235:genetics*; D002894:Chromosomes, Human, Pair 4 / Q000235:genetics*; D003131:Combined Modality Therapy; D016572:Cyclosporine / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007621:Karyotyping; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D014178:Translocation, Genetic
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D008775:Methylprednisolone